A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic

K. Hansel; A. Zangrilli; L. Bianchi; Ketty Peris; Andrea Chiricozzi; A. Offidani; F. Diotallevi; M. C. Fargnoli; Maria Concetta Fargnoli; M. Esposito; P. Amerio; G. Gualdi; L. Bianchi; L. Stingeni

doi:10.1111/jdv.17003

A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic

K. Hansel
, A. Zangrilli
, L. Bianchi
, Ketty Peris
, Andrea Chiricozzi
, A. Offidani
, F. Diotallevi
, M. C. Fargnoli
, Maria Concetta Fargnoli
, M. Esposito
, P. Amerio
, G. Gualdi
, L. Bianchi
, L. Stingeni

University of Perugia
University of Rome Tor Vergata
Marche Polytechnic University
University of L'Aquila
Gabriele d'Annunzio University

Risultato della ricerca: Contributo in rivista › Articolo

2 Citazioni (Scopus)

Abstract

na

Lingua originale	Inglese
pagine (da-a)	N/A-N/A
Rivista	Journal of the European Academy of Dermatology and Venereology
DOI	https://doi.org/10.1111/jdv.17003
Stato di pubblicazione	Pubblicato - 2020

Keywords

psoriasis
risankizumab

Accesso al documento

10.1111/jdv.17003

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Hansel, K., Zangrilli, A., Bianchi, L., Peris, K., Chiricozzi, A., Offidani, A., Diotallevi, F., Fargnoli, M. C., Fargnoli, M. C., Esposito, M., Amerio, P., Gualdi, G., Bianchi, L., & Stingeni, L. (2020). A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology, N/A-N/A. https://doi.org/10.1111/jdv.17003

@article{ebd2de88e3584565b1016b3421724bf9,

title = "A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic",

abstract = "na",

keywords = "psoriasis, risankizumab, psoriasis, risankizumab",

author = "K. Hansel and A. Zangrilli and L. Bianchi and Ketty Peris and Andrea Chiricozzi and A. Offidani and F. Diotallevi and Fargnoli, \{M. C.\} and Fargnoli, \{Maria Concetta\} and M. Esposito and P. Amerio and G. Gualdi and L. Bianchi and L. Stingeni",

year = "2020",

doi = "10.1111/jdv.17003",

language = "English",

pages = "N/A--N/A",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

}

Hansel, K, Zangrilli, A, Bianchi, L, Peris, K, Chiricozzi, A, Offidani, A, Diotallevi, F, Fargnoli, MC, Fargnoli, MC, Esposito, M, Amerio, P, Gualdi, G, Bianchi, L & Stingeni, L 2020, 'A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic', Journal of the European Academy of Dermatology and Venereology, pagg. N/A-N/A. https://doi.org/10.1111/jdv.17003

TY - JOUR

T1 - A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic

AU - Hansel, K.

AU - Zangrilli, A.

AU - Bianchi, L.

AU - Peris, Ketty

AU - Chiricozzi, Andrea

AU - Offidani, A.

AU - Diotallevi, F.

AU - Fargnoli, M. C.

AU - Fargnoli, Maria Concetta

AU - Esposito, M.

AU - Amerio, P.

AU - Gualdi, G.

AU - Bianchi, L.

AU - Stingeni, L.

PY - 2020

Y1 - 2020

N2 - na

AB - na

KW - psoriasis

KW - risankizumab

KW - psoriasis

KW - risankizumab

UR - http://hdl.handle.net/10807/168705

U2 - 10.1111/jdv.17003

DO - 10.1111/jdv.17003

M3 - Article

SN - 0926-9959

SP - N/A-N/A

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

ER -

A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo